USPTO serial 79203359
SANBIO
Reviewed by CopyMark Law Group
Reg. 5377414Status 739Renewal
- Filing date
- Status date
- Registration date
- Jan 16, 2018
- Examiner
- GILLES, DEBORAH LYNN MEINERS
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SANBIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $1,300
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
N. Alexander Nolte
N. Alexander Nolte Nolte Lackenbach Siegel111 Brook Street, Suite 101Scarsdale, NY 10583UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical, veterinary preparations and sanitary preparations for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations for regenerative medicine for medical purposes; medicines for treating central nervous system diseases; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for gene therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for cell therapy for medical purposes; pharmaceutical, veterinary preparations and sanitary preparations, namely, cells, stem cells and living cells for regenerative medicine for medical purposes | ACTIVE | — |
| 042 | Testing, inspection, research, development and evaluation services for others in the fields of pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals; consulting services in the field of pharmaceutical research and development; and testing, inspection, research, or development of pharmaceutical preparations for gene therapy, cell therapy, regenerative medicine and medicines for treating central nervous system diseases; conducting clinical trials for others in the field of pharmaceutical products, providing medical and scientific research information in the field of pharmaceutical products, and consulting services in the field of pharmaceutical product research and development; conducting clinical trials for others, providing medical and scientific research information in the field of clinical trials, and consulting services for others in the field of design, planning, and implementation project management of clinical trials; medical research, compiling data for research purposes in the field of medical consultancy, and providing medical research information in the field of pharmaceuticals, gene therapy, cell therapy for medical purposes, regenerative medicine and medicines for treating central nervous system diseases; scientific research and development, scientific research, analysis, and testing in the field of pharmaceutical product development, gene therapy development, cell therapy for medical purposes development, regenerative medicine development and central nervous system diseases therapy development, consulting services in the field of pharmaceutical product research and development, gene therapy research and development, cell therapy for medical purposes research and development, regenerative medicine research and development and central nervous system diseases therapy medicine research and development, and providing scientific research information in the field of pharmaceuticals, gene therapy, cell therapy regenerative medicine and central nervous system diseases therapy medicine | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SanBio Company Limited
- Other trademarks owned by SanBio Company Limited
- Other trademarks owned by SanBio Company Limited
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named SANBIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 23, 2026 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Jun 25, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 8, 2024 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Jul 8, 2024 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Jul 2, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 24, 2023 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jan 16, 2023 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jun 15, 2018 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 20, 2018 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 20, 2018 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 16, 2018 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 16, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 31, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 31, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 29, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Oct 11, 2017 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 11, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 11, 2017 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Sep 26, 2017 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 25, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 25, 2017 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 25, 2017 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2017 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 25, 2017 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Sep 2, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 2, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 31, 2017 | ALIE | ASSIGNED TO LIE | — |
| Aug 16, 2017 | PARI | TEAS VOLUNTARY AMENDMENT RECEIVED | — |
| Aug 15, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 14, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 15, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 28, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 28, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 26, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 25, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 21, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 17, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 17, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 16, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |